3.22.2 html 134 179 1 false 31 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Income (Unaudited) Sheet http://landosbiopharma.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossIncomeUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss Income (Unaudited) Statements 4 false false R5.htm 100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://landosbiopharma.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 100060 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) Sheet http://landosbiopharma.com/20220630/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) Statements 6 false false R7.htm 100070 - Disclosure - Organization and Description of the Business Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusiness Organization and Description of the Business Notes 7 false false R8.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100090 - Disclosure - Fair Value Measurement Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurement Fair Value Measurement Notes 9 false false R10.htm 100100 - Disclosure - Balance Sheet Components Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureBalanceSheetComponents Balance Sheet Components Notes 10 false false R11.htm 100110 - Disclosure - Stockholders Equity (Deficit) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureStockholdersEquityDeficit Stockholders Equity (Deficit) Notes 11 false false R12.htm 100120 - Disclosure - Commitments and Contingencies Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 100150 - Disclosure - License Agreement Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureLicenseAgreement1 License Agreement Notes 13 false false R14.htm 100160 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 14 false false R15.htm 100170 - Disclosure - Summary Of Significant Accounting Policies (Tables) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary Of Significant Accounting Policies (Tables) Tables 15 false false R16.htm 100180 - Disclosure - Fair Value Measurement (Tables) Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementTables Fair Value Measurement (Tables) Tables http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurement 16 false false R17.htm 100190 - Disclosure - Balance Sheet Components (Tables) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureBalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://landosbiopharma.com/20220630/taxonomy/role/DisclosureBalanceSheetComponents 17 false false R18.htm 100200 - Disclosure - Stockholders Equity (Deficit) (Tables) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureStockholdersEquityDeficitTables Stockholders Equity (Deficit) (Tables) Tables http://landosbiopharma.com/20220630/taxonomy/role/DisclosureStockholdersEquityDeficit 18 false false R19.htm 100220 - Disclosure - Organization and Description of the Business - Additional Information (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails Organization and Description of the Business - Additional Information (Details) Details 19 false false R20.htm 100230 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 20 false false R21.htm 100240 - Disclosure - Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfComputationOfBasicAndDilutedNetIncomeLossPerShareDetails Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share (Details) Details 21 false false R22.htm 100250 - Disclosure - Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Potentially Dilutive Securities Excluded from Diluted Net Loss Per (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfOutstandingSharesOfPotentiallyDilutiveSecuritiesExcludedFromDilutedNetLossPerDet Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Potentially Dilutive Securities Excluded from Diluted Net Loss Per (Details) Details 22 false false R23.htm 100260 - Disclosure - Fair Value Measurement - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurement - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 23 false false R24.htm 100270 - Disclosure - Fair Value Measurement - Contractual Maturities of Available for Sale Securities (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementContractualMaturitiesOfAvailableForSaleSecuritiesDetails Fair Value Measurement - Contractual Maturities of Available for Sale Securities (Details) Details 24 false false R25.htm 100280 - Disclosure - Fair Value Measurement - Additional Information (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureFairValueMeasurementAdditionalInformationDetails Fair Value Measurement - Additional Information (Details) Details 25 false false R26.htm 100290 - Disclosure - Balance Sheet Components - Schedule of Property Plant and Equipment (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentDetails Balance Sheet Components - Schedule of Property Plant and Equipment (Details) Details 26 false false R27.htm 100300 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedLiabilitiesDetails Balance Sheet Components - Schedule of Accrued Liabilities (Details) Details 27 false false R28.htm 100310 - Disclosure - Balance Sheet Components - Additional Information (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails Balance Sheet Components - Additional Information (Details) Details 28 false false R29.htm 100320 - Disclosure - Stockholders Equity (Deficit) - Additional Information (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails Stockholders Equity (Deficit) - Additional Information (Details) Details http://landosbiopharma.com/20220630/taxonomy/role/DisclosureStockholdersEquityDeficitTables 29 false false R30.htm 100330 - Disclosure - Stockholders Equity (Deficit) - Summary of Stock-Based Compensation Expenses (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureStockholdersEquityDeficitSummaryOfStockbasedCompensationExpensesDetails Stockholders Equity (Deficit) - Summary of Stock-Based Compensation Expenses (Details) Details http://landosbiopharma.com/20220630/taxonomy/role/DisclosureStockholdersEquityDeficitTables 30 false false R31.htm 100340 - Disclosure - Commitments and Contingencies (Additional Information) (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies (Additional Information) (Details) Details http://landosbiopharma.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies 31 false false R32.htm 100360 - Disclosure - License Agreement - Additional Information (Details) Sheet http://landosbiopharma.com/20220630/taxonomy/role/DisclosureLicenseAgreementAdditionalInformationDetails License Agreement - Additional Information (Details) Details 32 false false All Reports Book All Reports labp-20220630.htm labp-20220630.xsd labp-20220630_cal.xml labp-20220630_def.xml labp-20220630_lab.xml labp-20220630_pre.xml labp-ex10_1.htm labp-ex10_2.htm labp-ex31_1.htm labp-ex32_1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true